Project Details
| Short title | AURA-IPF |
|---|---|
| Status | Active |
| Effective start/end date | 16/07/26 → 15/07/28 |
Keywords
- clinical trials
- AP02-003
- Idiopathic Pulmonary Fibrosis
- AURA-IPF
Clinical Trial Phase
- Phase II
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Proof of Concept (POC) Study Evaluating the Safety, Tolerability, and Efficacy of Nintedanib Solution for Inhalation (AP02) in Participants with Idiopathic Pulmonary Fibrosis (IPF) (AURA-IPF)
- Glaspole, Ian (Chief Investigator (CI))
Project: Research